Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
复制标题
DOI:
10.1371/journal.pone.0060574
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Castillo-Olivares J
中科院分区:
文献类型:
--
作者:
Jabbar TK;Calvo-Pinilla E;Mateos F;Gubbins S;Bin-Tarif A;Bachanek-Bankowska K;Alpar O;Ortego J;Takamatsu HH;Mertens PP;Castillo-Olivares J
The protective efficacy of recombinant vaccines expressing serotype 8 bluetongue virus (BTV-8) capsid proteins was tested in a mouse model. The recombinant vaccines comprised plasmid DNA or Modified Vaccinia Ankara viruses encoding BTV VP2, VP5 or VP7 proteins. These constructs were administered alone or in combination using either a homologous prime boost vaccination regime (rMVA/rMVA) or a heterologous vaccination regime (DNA/rMVA). The DNA/rMVA or rMVA/rMVA prime-boost were administered at a three week interval and all of the animals that received VP2 generated neutralising antibodies. The vaccinated and non-vaccinated-control mice were subsequently challenged with a lethal dose of BTV-8. Mice vaccinated with VP7 alone were not protected. However, mice vaccinated with DNA/rMVA or rMVA/rMVA expressing VP2, VP5 and VP7 or VP2 alone were all protected.
登录
查看更多内容
影响因子:
3.7
作者:
Calvo-Pinilla E;Navasa N;Anguita J;Ortego J
通讯作者:
Ortego J
影响因子:
5.5
作者:
Franceschi, Valentina;Capocefalo, Antonio;Donofrio, Gaetano
通讯作者:
Donofrio, Gaetano
影响因子:
5.5
作者:
Fournillier, A.;Gerossier, E.;Inchauspe, G.
通讯作者:
Inchauspe, G.
影响因子:
64.8
作者:
Grimes, JM;Burroughs, JN;Stuart, DI
通讯作者:
Stuart, DI
影响因子:
6.9
作者:
Golde, WT;Gollobin, P;Rodriguez, LL
通讯作者:
Rodriguez, LL